Host–Microbe Interactions and Pathogenesis: Principles and Mechanisms

Host–Microbe Interactions and Pathogenesis

Introduction

This chapter explores the complex relationships between hosts and microbes, focusing on the mechanisms by which microbes establish infection, evade host defenses, and cause disease. Key concepts include the role of the normal microbiota, virulence factors, steps of infection, and strategies for transmission control.

Microbiota

Normal Microbiota and Their Roles

• Normal microbiota colonize the skin, digestive, genital, urinary, and respiratory systems.

• They manufacture vitamins, compete with pathogens, and promote immune system maturation.

• Dysbiosis: Disruption of the microbiota, which can compromise health and lead to disease.

Microbiota and Disease

• Microbiota composition varies between individuals; a harmless species in one host may be pathogenic in another.

• Example: Group B streptococci (GBS) are normal in ~30% of women but can cause severe disease in newborns.

• The immune system maintains a balanced response to resident microbes.

• Opportunistic pathogens: Normally harmless microbes that cause disease under certain conditions (e.g., E. coli outside the gut, yeast infections in immunocompromised hosts).

Virulence

Pathogenicity and Virulence

• Pathogenicity: The ability of a microbe to cause disease.

• Virulence: The degree or extent of disease caused by a pathogen.

• Tropism: Pathogen preference for specific hosts or tissues, which can change over time.

• Host factors (age, health, habits) influence disease development.

Virulence Factors

• Virulence factors help pathogens overcome host defenses and cause damage by:

  • Directly damaging host cells

  • Provoking harmful immune responses

• Examples: Toxins, enzymes, adhesins, immune evasion mechanisms.

• Pathogens balance virulence to persist in populations; highly lethal pathogens may cause isolated outbreaks.

• Virulence factors are often linked to transmission strategies (e.g., STIs are often minimally symptomatic).

• Pathogens may lose virulence factors (attenuation) when grown in culture, which is used in vaccine development.

Measuring Infectivity and Toxicity

• Infectious dose-50 (ID50): Number of cells/virions needed to infect 50% of hosts; lower ID50 means higher infectivity.

• Lethal dose-50 (LD50): Amount of toxin needed to kill 50% of hosts; lower LD50 means higher toxicity.

Toxins

• Toxins: Molecules that cause adverse effects (e.g., tissue damage, immune suppression).

• Toxigenic: Microbes that produce toxins.

• Toxemia: Presence of toxins in the bloodstream.

Endotoxins vs. Exotoxins

• Endotoxins: Lipid A component of lipopolysaccharide (LPS) in Gram-negative bacteria; released when bacteria die or divide.

• Exotoxins: Soluble proteins secreted by both Gram-positive and Gram-negative bacteria; highly toxic and specific in action.

Structure of LPS

• LPS consists of O antigen, core polysaccharide, and Lipid A (endotoxin).

Endotoxemia and Clinical Impact

• Endotoxemia: Endotoxin in the bloodstream, often from Gram-negative infections or medical procedures.

• Symptoms: Fever, chills, hypotension, tachycardia, inflammation, organ failure (septic shock).

• Endotoxins are not easily neutralized and no vaccines exist; contamination prevention is critical in healthcare.

Exotoxin Classification

• Exotoxins are classified by their target or action:

  • Neurotoxins: Affect the nervous system

  • Enterotoxins: Target the GI tract

  • Hepatotoxins: Affect the liver

  • Nephrotoxins: Damage the kidneys

• Three main families based on mode of action:

  • Type I: Membrane-acting extracellular toxins (alter cell signaling)

  • Type II: Membrane-damaging toxins (form pores or disrupt membranes)

  • Type III: Intracellular toxins (AB toxins; enter cells and disrupt function)

Steps of Infection

Overview of Infection Process

To establish infection, a pathogen must:

1. Enter the host

2. Adhere to host tissues

3. Invade tissues and obtain nutrients

4. Replicate while evading immune defenses

5. Transmit to a new host

Portal of Entry

• Common portals: Mucous membranes (respiratory, GI, urogenital), skin, conjunctiva, parenteral routes (bites, cuts, injections).

• Respiratory tract is the most common portal of entry.

Adherence to Host Tissues

• Pathogens use adhesins (e.g., fimbriae, pili, capsules) to attach to host cells.

• Biofilms play a major role in chronic infections and device-associated infections.

Invasion and Nutrient Acquisition

• Pathogens may remain on the surface, invade deeper tissues, or become intracellular.

• Invasins: Enzymes that help pathogens invade tissues (e.g., collagenases, coagulases).

• Pathogens compete for nutrients, especially iron, using molecules like siderophores.

• Extracellular enzymes (lipases, proteases) break down host tissues for nutrients.

• Pathogens can cause cytopathic effects: cell death (cytocidal) or cell damage (noncytocidal).

Immune Evasion and Replication

• Pathogens evade the immune system by:

  • Hiding inside host cells (intracellular pathogens)

  • Latency (e.g., herpesviruses, HIV)

  • Antigenic masking, mimicry, and variation

  • Interfering with phagocytosis or immune signaling

  • Suppressing immune responses (e.g., proteases that degrade antibodies)

Transmission to New Hosts

• Portal of exit: Route used by pathogens to leave the host (e.g., feces, urine, blood, saliva, respiratory droplets).

• Reservoirs: Environmental sources, animals, humans, or fomites.

Transmission Control

Biosafety Levels (BSL)

• BSL-1: Minimal risk, standard precautions (e.g., Bacillus subtilis).

• BSL-2: Moderate risk, not airborne, includes most clinical pathogens (e.g., Staphylococcus aureus).

• BSL-2+: Dangerous, incurable, not airborne (e.g., HIV).

• BSL-3: Serious/lethal, often airborne (e.g., Mycobacterium tuberculosis).

• BSL-4: High risk, exotic, no treatment (e.g., Ebola virus).

Infection Control Practices

• Universal and standard precautions: Hand hygiene, gloves, barrier clothing, proper waste management, and disinfection.

• Transmission precautions: Additional measures for contact, droplet, or airborne pathogens (e.g., isolation rooms, masks, limited transport).

Tables

Comparing Endotoxins and Exotoxins

Properties	Endotoxins	Exotoxins
Made of	Lipid	Protein
Made by	Gram-negative bacteria	Gram-negative and Gram-positive bacteria
Released from	Cell wall when bacteria divide or die	Actively growing bacteria
Vaccines	No	Yes (some)
Fever	Yes	Sometimes (certain superantigens)
Can be neutralized in patient	No	Yes (some)
Toxicity level	Lower (relatively high LD50)	Higher (many have a low LD50)

Examples of Pathogen Adhesins

Adhesin	Mechanism	Examples
Fimbriae or pili	Bind carbohydrates on host cells	E. coli (GI/urinary infections)
Sialic acid binding factors	Bind to sialic acid on host cells	Influenza virus
Heparan and heparin sulfate binding factors	Bind to heparan sulfate on host cells	Borrelia burgdorferi (Lyme disease)
Fibronectin binding factors	Bind to fibronectin in host tissues	Staphylococcus aureus

Examples of Invasins

Invasin	Mechanism	Examples
Flagella	Motility, chemotaxis	E. coli, Pseudomonas aeruginosa
Collagenases	Break down collagen	Clostridium perfringens
Neuraminidases	Break down sialic acid	Influenza virus
Coagulases	Promote clotting	Staphylococcus aureus
Kinases	Break down clots	Streptococcus pyogenes

Summary

• Host–microbe interactions are dynamic and influenced by both microbial and host factors.

• Virulence factors enable pathogens to infect, evade defenses, and cause disease.

• Understanding these mechanisms is essential for infection control and clinical management.